Steven A. Shallcross - CEO and CFO, Director at Theriva Biologics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Steven A. Shallcross since 12 Aug 2025

Reported holdings for Steven A. Shallcross in Theriva Biologics, Inc.

Form 4 holding CEO and CFO, Director

Theriva Biologics, Inc.

Security class
Stock Options (right to buy)
Shares / value
475,000
Estimated value
Report date
05 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Steven A. Shallcross in Theriva Biologics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .